Savara Inc Operating Leases, Rent Expense, Minimum Rentals
Savara Inc (SVRA) reported Operating Leases, Rent Expense, Minimum Rentals of $100.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseMinimumRentals · last filed 2021-03-10
- Savara Inc operating leases, rent expense, minimum rentals for the quarter ending 2020-12-31 was $0.00.
- Savara Inc operating leases, rent expense, minimum rentals for the quarter ending 2020-09-30 was $0.00.
- Savara Inc operating leases, rent expense, minimum rentals for the quarter ending 2020-06-30 was $0.00.
- Savara Inc operating leases, rent expense, minimum rentals for the quarter ending 2020-03-31 was $100.00K, a 0.00% change year-over-year.
- Savara Inc operating leases, rent expense, minimum rentals for fiscal 2020 was $100.00K, a 0.00% change from fiscal 2019.
- Savara Inc operating leases, rent expense, minimum rentals for fiscal 2019 was $100.00K, a 0.00% change from fiscal 2018.
- Savara Inc operating leases, rent expense, minimum rentals for fiscal 2018 was $100.00K.
- Savara Inc operating leases, rent expense, minimum rentals for fiscal 2016 was $41.00K, a 0.00% change from fiscal 2015.
| Period end | Operating Leases, Rent Expense, Minimum Rentals 0 month | Operating Leases, Rent Expense, Minimum Rentals 0 month as first filed | Operating Leases, Rent Expense, Minimum Rentals 1 month | Operating Leases, Rent Expense, Minimum Rentals 3 month | Operating Leases, Rent Expense, Minimum Rentals 6 month | Operating Leases, Rent Expense, Minimum Rentals 9 month | Operating Leases, Rent Expense, Minimum Rentals 12 month | Operating Leases, Rent Expense, Minimum Rentals 23 month |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $0.00 derived: sum of 2 quarters · filed 2021-03-10 | $0.00 derived: sum of 3 quarters · filed 2021-03-10 | $100.00K 10-K · filed 2021-03-10 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $100.00K 10-Q · filed 2020-11-05 | $100.00K derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $100.00K 10-Q · filed 2020-08-06 | $100.00K derived: sum of 3 quarters · filed 2020-08-06 | $100.00K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2020-03-31 | $100.00K 10-Q · filed 2020-05-07 | $100.00K derived: sum of 2 quarters · filed 2020-05-07 | $100.00K derived: sum of 3 quarters · filed 2020-05-07 | $100.00K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $100.00K 10-K · filed 2020-03-12 | ||||
| 2019-11-30 | $100.00K 10-K · filed 2020-03-12 | |||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $100.00K 10-Q · filed 2019-11-07 | $194.00K derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $100.00K 10-Q · filed 2019-08-08 | $194.00K derived: sum of 3 quarters · filed 2019-08-08 | |||||
| 2019-03-31 | $100.00K 10-Q · filed 2019-05-09 | $194.00K derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2018-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $100.00K 10-K · filed 2019-03-13 | ||||||
| 2018-09-30 | $6.00K 10-Q · filed 2018-11-07 | |||||||
| 2017-11-29 | $200.00K 10-K · filed 2021-03-10 | $13.00K 10-K · filed 2018-03-14 | ||||||
| 2017-03-23 | $44.00K 10-Q · filed 2018-11-07 | |||||||
| 2016-12-31 | $41.00K 10-K · filed 2017-03-06 | |||||||
| 2015-12-31 | $41.00K 10-K · filed 2016-03-14 | |||||||
| 2014-12-31 | $41.00K 10-K · filed 2015-03-24 | |||||||
| 2014-06-01 | $5.00K 10-Q · filed 2018-08-09 | |||||||
| 2013-12-31 | $26.68K 10-K · filed 2014-03-26 | |||||||
| 2012-01-31 | $23.80K 10-K · filed 2013-03-19 | |||||||
| 2011-01-31 | $16.90K 10-K · filed 2013-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |